Valuation: Gerresheimer AG

Capitalization 857M 994M 785M 742M 1.37B 96.23B 1.4B 9.36B 3.64B 45.3B 3.73B 3.65B 158B P/E ratio 2025 *
2,886x
P/E ratio 2026 * 19x
Enterprise value 2.88B 3.34B 2.64B 2.5B 4.6B 324B 4.72B 31.49B 12.26B 152B 12.55B 12.28B 532B EV / Sales 2025 *
1.25x
EV / Sales 2026 * 1.23x
Free-Float
89.83%
Yield 2025 *
2.63%
Yield 2026 * 2.53%
1 day-1.19%
1 week-12.61%
Current month+1.14%
1 month+16.42%
3 months+18.98%
6 months+2.48%
Current year-10.01%
1 week 23.68
Extreme 23.68
26.5
1 month 20.96
Extreme 20.96
28.88
Current year 14.83
Extreme 14.83
28.88
1 year 14.83
Extreme 14.83
66.5
3 years 14.83
Extreme 14.83
122.9
5 years 14.83
Extreme 14.83
122.9
10 years 14.83
Extreme 14.83
122.9
Manager TitleAgeSince
Chief Executive Officer 64 21/06/2010
Director of Finance/CFO 55 31/08/2025
Investor Relations Contact - -
Director TitleAgeSince
Chairman 68 29/04/2015
Director/Board Member 57 04/06/2024
Director/Board Member 54 31/12/2010
Change 5d. change 1-year change 3-years change Capi.($)
-1.19%-12.61%-58.87%-75.57% 1.01B
+1.04%+5.30%-34.47%-18.46% 153B
+1.63%+2.29%-9.65%-12.03% 99.27B
-2.04%-5.09%+47.25%+61.66% 58.38B
+1.64%+2.01%-9.04%+53.51% 50.95B
+3.23%-0.38%-17.00%-41.66% 39.22B
+4.66%-2.20% - - 30.46B
+2.86%+9.50%-23.01%-42.84% 25.12B
-0.16%-2.61%+39.92%-13.51% 21.51B
+0.63%+18.23%-14.42%+8.78% 21.16B
Average +1.19%+1.60%-8.81%-8.90% 50.02B
Weighted average by Cap. +1.23%+3.19%-9.98%-1.25%

Financials

2025 *2026 *
Net sales 2.31B 2.68B 2.12B 2B 3.69B 259B 3.78B 25.21B 9.82B 122B 10.05B 9.83B 426B 2.36B 2.73B 2.16B 2.04B 3.76B 265B 3.86B 25.74B 10.03B 125B 10.26B 10.04B 435B
Net income 3.36M 3.89M 3.08M 2.91M 5.36M 377M 5.49M 36.65M 14.27M 177M 14.61M 14.3M 620M 56.94M 66.02M 52.16M 49.29M 90.87M 6.39B 93.16M 622M 242M 3.01B 248M 242M 10.51B
Net Debt 2.03B 2.35B 1.86B 1.75B 3.23B 228B 3.32B 22.13B 8.62B 107B 8.82B 8.63B 374B 2.04B 2.36B 1.87B 1.76B 3.25B 229B 3.33B 22.24B 8.66B 108B 8.86B 8.67B 376B
Logo Gerresheimer AG
Gerresheimer AG is a Germany-based company that is active in the pharmaceuticals and health care industry. It operates through two business segments: Plastics and Devices, and Primary Packaging Glass. The Plastics and Devices segment produces standard and customized products for drug delivery, such as insulin pens, inhalers, and prefillable syrings. The Primary Packaging Glass segment focuses on the production of packaging of glass for medicines and cosmetics, such as pharmaceuticals jars, ampoules, injection vials, cartridges, perfume flacons and cream jars, as well as glass containers for the food and beverage industry. The Company operates approximately 40 production facilities in Europe, North America, South America and Asia.
Employees
13,535
Date Price Change Volume
19/05/26 24.82 -1.19% 128,339
18/05/26 25.12 +1.95% 139,841
15/05/26 24.64 -1.99% 263,030
14/05/26 25.14 -5.06% 261,982
13/05/26 26.48 -6.76% 296,765
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
24.82EUR
Average target price
23.37EUR
Spread / Average Target
-5.83%

Quarterly revenue - Rate of surprise